The Lupus Accelerating Breakthroughs Consortium (Lupus ABC), the public-private partnership which the LRA initiated with the U.S. Food and Drug Administration is working with many key lupus stakeholders on pursuing the most effective ways to accelerate lupus drug development. Read an interview with Dr. Patricia Katz who chairs the Lupus ABC Planning Committee on Patient Reported Outcomes. Dr. Katz provides information on what is meant by Patient Reported Outcomes, how these outcomes could impact clinical trials, and what the October meeting of this Committee aims to achieve.
